Hot Pursuit     31-Aug-23
Ajanta Pharma gains after receiving USFDA approval for Topiramate capsules
Ajanta Pharma rallied 3.03% to Rs 1,780.85 after the company received final approval from the US Food and Administration (USFDA) to market Topiramate extended-release capsules, 25 mg, 50 mg, 100 mg and 200 mg.
Topiramate is the generic version of Supernus Pharmaceuticals Inc's Trokendi XR. As per the settlement with the innovator, Ajanta can launch Topiramate on 01 February 2026 or earlier under certain circumstances.

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches.

Ajanta has received 50 final ANDA approvals, out of which 41 are commercialized. Ajanta also holds 2 tentative approvals and 22 ANDAs are awaiting USFDA approvals.

Ajanta Pharma is a specialty pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.

The company's consolidated net profit jumped 19% to Rs 208.12 crore on 7.4% increase in net sales to Rs 1021.04 crore in Q1 FY24 over Q1 FY23.

Previous News
  Ajanta Pharma consolidated net profit rises 65.82% in the March 2024 quarter
 ( Results - Announcements 02-May-24   16:53 )
  Ajanta Pharma
 ( Results - Analysis 30-Jul-24   18:28 )
  Ajanta Pharma
 ( Results - Analysis 01-Feb-24   11:01 )
  Ajanta Pharma consolidated net profit rises 18.09% in the June 2024 quarter
 ( Results - Announcements 30-Jul-24   16:46 )
  Ajanta Pharma spurts as Q4 PAT climbs 66% YoY, board OKs Rs 285-cr share buyback
 ( Hot Pursuit - 03-May-24   10:22 )
  Ajanta Pharma to convene board meeting
 ( Corporate News - 20-Jan-24   12:12 )
  Volumes spurt at Galaxy Surfactants Ltd counter
 ( Hot Pursuit - 21-Mar-24   14:30 )
  Ajanta Pharma's Dahej unit undergoes USFDA audit
 ( Corporate News - 12-Sep-22   12:00 )
  Ajanta Pharma slips after US FDA issues form 483 to Dahej facility
 ( Hot Pursuit - 12-Sep-22   11:59 )
  Ajanta Pharma to table results
 ( Corporate News - 21-Jul-22   15:18 )
  Volumes spurt at Shriram Finance Ltd counter
 ( Hot Pursuit - 08-Mar-23   11:00 )
Other Stories
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
  Power Grid Corporation of India Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top